Duska LR - Search Results

1

A Phase I study of continuous infusion doxorubicin and paclitaxel chemotherapy with granulocyte colony-stimulating factor for relapsed epithelial ovarian cancer.

Duska LR, Penson R, Supko JG, Finkelstein DM, Makastorsis T, Gallagher J, Borden K, Goodman A, Fuller AF, Nikrui N, Seiden MV. Duska LR, et al. Clin Cancer Res. 1999 Jun;5(6):1299-305. Clin Cancer Res. 1999. PMID: 10389912 Clinical Trial.

2

Clinical evaluation of atypical glandular cells of undetermined significance on cervical cytology.

Duska LR, Flynn CF, Chen A, Whall-Strojwas D, Goodman A. Duska LR, et al. Obstet Gynecol. 1998 Feb;91(2):278-82. doi: 10.1016/s0029-7844(97)00659-5. Obstet Gynecol. 1998. PMID: 9469289

3

Fallopian tube carcinoma.

Nikrui N, Duska LR. Nikrui N, et al. Among authors: duska lr. Surg Oncol Clin N Am. 1998 Apr;7(2):363-73. Surg Oncol Clin N Am. 1998. PMID: 9537982 Review.

4

Fertility options for patients with stages IA2 and IB cervical cancer: presentation of two cases and discussion of technical and ethical issues.

Duska LR, Toth TL, Goodman A. Duska LR, et al. Obstet Gynecol. 1998 Oct;92(4 Pt 2):656-8. doi: 10.1016/s0029-7844(98)00290-7. Obstet Gynecol. 1998. PMID: 9764652 Review.

5

Masculinizing sclerosing stromal cell tumor in pregnancy: report of a case and review of the literature.

Duska LR, Flynn C, Goodman A. Duska LR, et al. Eur J Gynaecol Oncol. 1998;19(5):441-3. Eur J Gynaecol Oncol. 1998. PMID: 9863907 Review.

6

Predictors of recurrence in surgical stage II endometrial adenocarcinoma.

Feltmate CM, Duska LR, Chang Y, Flynn CE, Nikrui N, Kiggundu E, Goodman A, Fuller AF, McIntyre JF. Feltmate CM, et al. Among authors: duska lr. Gynecol Oncol. 1999 Jun;73(3):407-11. doi: 10.1006/gyno.1999.5380. Gynecol Oncol. 1999. PMID: 10366468

7

Epithelial ovarian carcinoma in the reproductive age group.

Duska LR, Chang YC, Flynn CE, Chen AH, Goodman A, Fuller AF, Nikrui N. Duska LR, et al. Cancer. 1999 Jun 15;85(12):2623-9. doi: 10.1002/(sici)1097-0142(19990615)85:12<2623::aid-cncr19>3.0.co;2-o. Cancer. 1999. PMID: 10375111

8

Clinically significant venous thromboembolism after gynecologic surgery.

Schorge JO, Goldhaber SZ, Duska LR, Goodman A, Feldman S. Schorge JO, et al. Among authors: duska lr. J Reprod Med. 1999 Aug;44(8):669-73. J Reprod Med. 1999. PMID: 10483535

9

Combination photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo.

Duska LR, Hamblin MR, Miller JL, Hasan T. Duska LR, et al. J Natl Cancer Inst. 1999 Sep 15;91(18):1557-63. doi: 10.1093/jnci/91.18.1557. J Natl Cancer Inst. 1999. PMID: 10491432

10

Efficacy and hematologic toxicity of salvage chemotherapy following stem cell-supported high-dose chemotherapy in women with recurrent ovarian cancer.

Cook S, Penson R, Duska L, Nikrui N, Goodman A, Fuller A, Seiden M. Cook S, et al. Gynecol Oncol. 2000 Apr;77(1):48-54. doi: 10.1006/gyno.1999.5710. Gynecol Oncol. 2000. PMID: 10739690

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

169 results

Search Page

Filters